Gutiérrez-de-Terán H

A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models.

Tay AHM, Prieto-Díaz R, Neo S, ..., Sotelo E, Lundqvist A

J Immunother Cancer 10 (5) - [2022-05-00; online 2022-05-18]

Exploring Non-orthosteric Interactions with a Series of Potent and Selective A3 Antagonists.

Miranda-Pastoriza D, Bernárdez R, Azuaje J, ..., Gutiérrez-de-Terán H, Sotelo E

ACS Med. Chem. Lett. 13 (2) 243-249 [2022-02-10; online 2022-01-10]

Deciphering conformational selectivity in the A2A adenosine G protein-coupled receptor by free energy simulations.

Jespers W, Heitman LH, IJzerman AP, ..., Åqvist J, Gutiérrez-de-Terán H

PLoS Comput Biol 17 (11) e1009152 [2021-11-00; online 2021-11-24]

GPCRmd uncovers the dynamics of the 3D-GPCRome.

Rodríguez-Espigares I, Torrens-Fontanals M, Tiemann JKS, ..., Guixà-González R, Selent J

Nat. Methods 17 (8) 777-787 [2020-08-00; online 2020-07-13]

Jens Carlsson SciLifeLab Fellow

Publisher Correction: GPCRmd uncovers the dynamics of the 3D-GPCRome.

Rodríguez-Espigares I, Torrens-Fontanals M, Tiemann JKS, ..., Guixà-González R, Selent J

Nat. Methods 17 (8) 861-862 [2020-08-00; online 2020-07-25]

Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists.

Vasile S, Hallberg A, Sallander J, ..., Åqvist J, Gutiérrez-de-Terán H

Biomolecules 10 (4) - [2020-04-23; online 2020-04-23]

QligFEP: an automated workflow for small molecule free energy calculations in Q.

Jespers W, Esguerra M, Åqvist J, Gutiérrez-de-Terán H

J Cheminform 11 (1) 26 [2019-04-02; online 2019-04-02]